Schedule 13G ownership disclosure
Nexvet Biopharma plc
Security class unavailable · CUSIP: G6503X109
Event date: 2015-02-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,307,680
- Percent of class
- 11.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-15-000499
- Form type
- SC 13G
- Filer
- Nexvet Biopharma plc
- CIK
- CIK 1618561
- Filed
- Mar 10, 2015
- Reporting period
- Feb 27, 2015
- Description
- Schedule 13G beneficial ownership